lilly cares tirzepatide releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity FDA approves tirzepatide, Eli Lilly's
Description
They rationed their remaining supplies, stretching the weekly injections to 10 days, two weeks, even three weeks
Hanisch, 2002)
Variants in genes like GLP1R and GIPR may predict differential tolerability to GLP-1 agonists, potentially influencing optimal timing and dosing patterns
Participants also reported increased cognitive or dietary restraint (which relates to how much people intentionally limit their eating), but the researchers say more research is needed to understand this link
It reduces caloric intake
